BioCatalyst

JAZZ — Jazz Pharmaceuticals plc catalysts

2 verified catalyst event(s) for Jazz Pharmaceuticals plc (ticker JAZZ). Each is linked to its official source. Verified as of 2026-09-20.

Next verified catalyst

2026-09-30 — A Study of Zanidatamab in Combination With Chemotherapy Plus or Minus Tislelizumab in Pati · official source ↗

Upcoming

DateEventCompanyDrugOfficial source & verification
2026-09-30
in 10d
ESTIMATED
 READOUT
A Study of Zanidatamab in Combination With Chemotherapy Plus or Minus Tislelizum
Phase 3 · Gastric Neoplasms, Gastroesophageal Adenocarcinoma
 JAZZ Jazz Pharmaceuticals plc Zanidatamab, Tislelizumab, Trastuzumab, ClinicalTrials.gov ↗
✓ Source-checked 2026-09-20
Sponsor-projected date — can change
2026-12-31
in 3mo
ESTIMATED
 READOUT
A Phase 2 Study of Zanidatamab in Patients With HER2-expressing Tumors
Phase 2 · Breast Cancer, Gastric Cancer
 JAZZ Jazz Pharmaceuticals plc Zanidatamab ClinicalTrials.gov ↗
✓ Source-checked 2026-09-20
Sponsor-projected date — can change
Disclaimer. Bio Catalyst Calendar is a public-events data calendar. Every date is sourced and linked to an official record (ClinicalTrials.gov, FDA / Federal Register, openFDA). It is scheduling and reference data only — NOT investment advice, a recommendation, or a buy/sell signal. Dates set by sponsors and the FDA can change; always confirm against the linked official source.